Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma
Research paper by Coutre, S, Tedeschi, A, Robak, T, Barr, P. M, Owen, C, Bairey, O, Burger, J, Zhou, et al.
Indexed on: 10 Jun '18Published on: 04 Jun '18Published in: Haematologica
Join Sparrho today to stay on top of science
Discover, organise and share research that matters to you
Join Sparrho today to stay on top of science
Discover, organise and share research that matters to you
Join for free
Abstract
Authors: Coutre, S ; Tedeschi ; A ; Robak ; T ; Barr ; P. M ; Owen ; C ; Bairey ; O ; Burger ; J ; Zhou ; C ; Styles ; L ; James ; D. F ; Kipps ; T. J.
Article URL: http://www.haematologica.org/cgi/reprint/103/6/e249?rss=1
Citation: Vol 103 No. 6 (2018) pp e249 e251
Publication Date: 2018-06-03T23:55:04-07:00
Journal: Haematologica - the Hematology journal